Biotech · Private company
Guerbet
Track this companyFree. Adds Guerbet to your Dealase workspace and tells you when its record changes.
Clinical trials256 recruiting or active
Pipeline programs20From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline20
- Dotarem (gadoterate meglumine)Phase 3 · Diagnostic Self EvaluationClinicalTrials.gov · fetched Nov 12, 2026
- Gadobutrol 1 MMOLE/ML Intravenous SolutionPhase 3 · Lesion in Body RegionClinicalTrials.gov · fetched Nov 12, 2026
- Gadobutrol 1Mmol/mL Solution for Injection VialPhase 3 · CNS LesionClinicalTrials.gov · fetched Nov 12, 2026
- gadopiclenolPhase 3 · Steno-occlusive DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- gadopiclenolPhase 3 · CNS LesionClinicalTrials.gov · fetched Nov 12, 2026
- gadopiclenolPhase 3 · Lesion in Body RegionClinicalTrials.gov · fetched Nov 12, 2026
- Gadoterate meglumine (Dotarem)Phase 3 · Steno-occlusive DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Magnevist (gadopentetate dimeglumine)Phase 3 · Diagnostic Self EvaluationClinicalTrials.gov · fetched Nov 12, 2026
- Gadobenate dimegluminePhase 2 · CNS LesionClinicalTrials.gov · fetched Nov 12, 2026
- GadopiclenolPhase 2 · Central Nervous System DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- MRIPhase 2 · CNS LesionClinicalTrials.gov · fetched Nov 12, 2026
- P03277Phase 2 · CNS LesionClinicalTrials.gov · fetched Nov 12, 2026
- Cognitive TestsMotor FunctionClinicalTrials.gov · fetched Nov 12, 2026
- Gadobenate dimeglumineMotor FunctionClinicalTrials.gov · fetched Nov 12, 2026
- Gadolinium MeasurementsMotor FunctionClinicalTrials.gov · fetched Nov 12, 2026
- Gadoxetate disodiumMotor FunctionClinicalTrials.gov · fetched Nov 12, 2026
- Iodixanol 320 mgI/mLRenal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Ioversol 320 mgI/mLRenal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Motor TestsMotor FunctionClinicalTrials.gov · fetched Nov 12, 2026
- Unenhanced-MRI of the brainMotor FunctionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular DiseasePHASE3 · RECRUITING · started Jul 28, 2026ClinicalTrials.gov NCT07348640 · fetched Nov 12, 2026
- High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar AssessmentPHASE4 · RECRUITING · started Aug 1, 2025ClinicalTrials.gov NCT05954559 · fetched Nov 12, 2026
- Developing MRI Technologies for Atrial FibrillationENROLLING_BY_INVITATION · started Jan 16, 2025ClinicalTrials.gov NCT07083115 · fetched Nov 12, 2026
- Gadopiclenol vs Gadoxetate MRI for Liver LesionsENROLLING_BY_INVITATION · started Jul 1, 2024ClinicalTrials.gov NCT06596616 · fetched Nov 12, 2026
- Guerbet Liver FibrosisENROLLING_BY_INVITATION · started Feb 28, 2024ClinicalTrials.gov NCT06703450 · fetched Nov 12, 2026
- Gadopiclenol in Contrast Enhanced MRI of the ProstatePHASE4 · SUSPENDED · started Feb 14, 2024ClinicalTrials.gov NCT06226129 · fetched Nov 12, 2026
- Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical OutcomesPHASE1 · WITHDRAWN · started Dec 21, 2023ClinicalTrials.gov NCT05490381 · fetched Nov 12, 2026
- Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of AgePHASE2 · COMPLETED · started Sep 21, 2022ClinicalTrials.gov NCT05590884 · fetched Nov 12, 2026
- Genicular Artery Embolization (GAE) for the Treatment of Chronic Post Knee Arthroplasty PainNA · WITHDRAWN · started Jul 1, 2022ClinicalTrials.gov NCT05248308 · fetched Nov 12, 2026
- A Zero Acute Kidney Injury Strategy for Percutaneous Coronary Intervention in Patients With ChronicKidney DiseaseWITHDRAWN · started Jan 1, 2022ClinicalTrials.gov NCT04928092 · fetched Nov 12, 2026
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsPHASE4 · RECRUITING · started Mar 24, 2021ClinicalTrials.gov NCT04373564 · fetched Nov 12, 2026
- Dotarem vs Gadobutrol Contrast for Breast MRIPHASE4 · COMPLETED · started Mar 1, 2021ClinicalTrials.gov NCT03730051 · fetched Nov 12, 2026
- Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)EARLY_PHASE1 · COMPLETED · started Jul 13, 2020ClinicalTrials.gov NCT04341129 · fetched Nov 12, 2026
- Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)PHASE3 · COMPLETED · started Aug 27, 2019ClinicalTrials.gov NCT03986138 · fetched Nov 12, 2026
- Dotarem Evaluation for Myocardial Perfusion CMRCOMPLETED · started Jul 3, 2019ClinicalTrials.gov NCT03937921 · fetched Nov 12, 2026
- Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)PHASE3 · COMPLETED · started Jun 3, 2019ClinicalTrials.gov NCT03996447 · fetched Nov 12, 2026
- Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial)PHASE4 · COMPLETED · started Jan 11, 2019ClinicalTrials.gov NCT03604549 · fetched Nov 12, 2026
- Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRICOMPLETED · started Feb 9, 2017ClinicalTrials.gov NCT03023566 · fetched Nov 12, 2026
- P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)PHASE2 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02633501 · fetched Nov 12, 2026
- Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the LiverPHASE2 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02724540 · fetched Nov 12, 2026
- Evaluation of Gadoterate in Patients With Renal DysfunctionPHASE4 · TERMINATED · started Nov 5, 2014ClinicalTrials.gov NCT02382380 · fetched Nov 12, 2026
- Long-Term Retention of Gadolinium in BoneNA · COMPLETED · started May 6, 2013ClinicalTrials.gov NCT01853163 · fetched Nov 12, 2026
- Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem AdministrationCOMPLETED · started May 1, 2011ClinicalTrials.gov NCT01467271 · fetched Nov 12, 2026
- Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) LesionsPHASE3 · COMPLETED · started Sep 1, 2010ClinicalTrials.gov NCT01211873 · fetched Nov 12, 2026
- Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed TomographyPHASE4 · TERMINATED · started Jan 1, 2009ClinicalTrials.gov NCT00793182 · fetched Nov 12, 2026